
Ernesto Arturio Grano
Examiner (ID: 19022)
| Most Active Art Unit | 3735 |
| Art Unit(s) | 3728, 3788, 3735, 4147 |
| Total Applications | 1168 |
| Issued Applications | 657 |
| Pending Applications | 77 |
| Abandoned Applications | 448 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16511461
[patent_doc_number] => 20200390718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATED ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 16/885758
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885758 | METHODS AND COMPOSITIONS FOR ATTENUATED ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSE | May 27, 2020 | Abandoned |
Array
(
[id] => 17719131
[patent_doc_number] => 20220211850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => GAS-FILLED MICROVESICLES
[patent_app_type] => utility
[patent_app_number] => 17/610853
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610853 | Gas-filled microvesicles | May 13, 2020 | Issued |
Array
(
[id] => 17821430
[patent_doc_number] => 11426352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Freeze-dried product and gas-filled microvesicles suspension
[patent_app_type] => utility
[patent_app_number] => 17/611034
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7811
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611034 | Freeze-dried product and gas-filled microvesicles suspension | May 13, 2020 | Issued |
Array
(
[id] => 17212969
[patent_doc_number] => 20210346305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ORGANOSILICON CARRIERS FOR USE IN TREATING INFECTIONS AND/OR DISEASES CAUSED BY SARS VIRUSES
[patent_app_type] => utility
[patent_app_number] => 16/871317
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871317 | Organosilicon carriers for use in treating infections and/or diseases caused by SARS viruses | May 10, 2020 | Issued |
Array
(
[id] => 16251990
[patent_doc_number] => 20200261364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DELIVERY OF AGENTS USING METASTABLE LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/866140
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866140 | Delivery of agents using metastable liposomes | May 3, 2020 | Issued |
Array
(
[id] => 18101144
[patent_doc_number] => 11541010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Amphoteric liposomes comprising imino lipids
[patent_app_type] => utility
[patent_app_number] => 16/866363
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15695
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866363 | Amphoteric liposomes comprising imino lipids | May 3, 2020 | Issued |
Array
(
[id] => 16451027
[patent_doc_number] => 20200360453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/860729
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860729 | METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY TO VIRAL TRANSFER VECTORS | Apr 27, 2020 | Abandoned |
Array
(
[id] => 16420432
[patent_doc_number] => 20200345630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => TRANS-TYMPANIC MEMBRANE DELIVERY PLATFORM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/859422
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/859422 | Trans-tympanic membrane delivery platform and uses thereof | Apr 26, 2020 | Issued |
Array
(
[id] => 17685696
[patent_doc_number] => 20220192988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR PREPARING STABLE PEPTIDE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/606214
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/606214 | Method for preparing stable peptide formulations | Apr 19, 2020 | Issued |
Array
(
[id] => 16320086
[patent_doc_number] => 10780032
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-09-22
[patent_title] => Oral care compositions for active agent delivery
[patent_app_type] => utility
[patent_app_number] => 16/850035
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 41828
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850035 | Oral care compositions for active agent delivery | Apr 15, 2020 | Issued |
Array
(
[id] => 16397114
[patent_doc_number] => 20200337972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => Reduction Of Tooth Staining Derived From Cationic Antimicrobials
[patent_app_type] => utility
[patent_app_number] => 16/850051
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850051
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850051 | Reduction of tooth staining derived from cationic antimicrobials | Apr 15, 2020 | Issued |
Array
(
[id] => 17655222
[patent_doc_number] => 20220175687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => NANOPARTICLES FOR DRUG DELIVERY TO BRAIN
[patent_app_type] => utility
[patent_app_number] => 17/602664
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602664 | Nanoparticles for drug delivery to brain | Apr 12, 2020 | Issued |
Array
(
[id] => 16203955
[patent_doc_number] => 20200236945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Oral Care Compositions and Methods for Anti-Attachment Polymers and Coatings
[patent_app_type] => utility
[patent_app_number] => 16/846770
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846770
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846770 | Oral care compositions and methods for anti-attachment polymers and coatings | Apr 12, 2020 | Issued |
Array
(
[id] => 18525430
[patent_doc_number] => 11712408
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Semisolid oral dispersions comprising active agents
[patent_app_type] => utility
[patent_app_number] => 16/842806
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 33993
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842806
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842806 | Semisolid oral dispersions comprising active agents | Apr 7, 2020 | Issued |
Array
(
[id] => 16389399
[patent_doc_number] => 20200330340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Semisolid Oral Dispersions Comprising Active Agents
[patent_app_type] => utility
[patent_app_number] => 16/842797
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842797 | Semisolid oral dispersions comprising active agents | Apr 7, 2020 | Issued |
Array
(
[id] => 17350141
[patent_doc_number] => 11224760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Semisolid oral dispersions comprising bleaching agents
[patent_app_type] => utility
[patent_app_number] => 16/842800
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 33957
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842800
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842800 | Semisolid oral dispersions comprising bleaching agents | Apr 7, 2020 | Issued |
Array
(
[id] => 16389265
[patent_doc_number] => 20200330206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Multi-Phase Oral Care Compositions
[patent_app_type] => utility
[patent_app_number] => 16/842799
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842799
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842799 | Multi-phase oral care compositions | Apr 7, 2020 | Issued |
Array
(
[id] => 18259702
[patent_doc_number] => 11607386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Liposomes encapsulating adenosine
[patent_app_type] => utility
[patent_app_number] => 17/601032
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 16
[patent_no_of_words] => 9442
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601032 | Liposomes encapsulating adenosine | Apr 2, 2020 | Issued |
Array
(
[id] => 18199265
[patent_doc_number] => 20230052784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => A DELIVERY SYSTEM COMPRISING SILICON NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/598703
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598703 | Delivery system comprising silicon nanoparticles | Mar 29, 2020 | Issued |
Array
(
[id] => 16341538
[patent_doc_number] => 20200306188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => In Vivo Targeting of Extracellular Vesicles
[patent_app_type] => utility
[patent_app_number] => 16/834048
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834048 | In vivo targeting of extracellular vesicles | Mar 29, 2020 | Issued |